Other
Cumulative Cost Basis
Gilead Sciences Cumulative Cost Basis increased by 1.4% to $8.42B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 5.8%, from $7.96B to $8.42B. Over 2 years (FY 2020 to FY 2025), Cumulative Cost Basis shows an upward trend with a 102.6% CAGR.
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ1 2016
Last reportedQ1 2026May 7, 2026
How to read this metric
Provides a stable reference point for the scale of the bank's investment activities and historical capital deployment.
Detailed definition
The cumulative cost basis represents the original purchase price or historical cost of assets or liabilities before any...
Peer comparison
Universal accounting concept used by all financial institutions to track historical investment scale.
Metric ID:
cumulative_cost_basisHistorical Data
6 periods
| Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|
| Value | $7.88B | $7.96B | $8.08B | $8.19B | $8.30B | $8.42B |
| QoQ Change | — | +1.0% | +1.5% | +1.4% | +1.3% | +1.4% |
| YoY Change | — | — | — | — | +5.3% | +5.8% |
Range$7.88B – $8.42B
CAGR+5.4%
Avg YoY Growth+5.5%
Median YoY Growth+5.5%
Current Streak5+ quarters growth
Cumulative Cost Basis at Other Companies
Frequently Asked Questions
- What is Gilead Sciences's cumulative cost basis?
- Gilead Sciences (GILD) reported cumulative cost basis of $8.42B in Q1 2026.
- How has Gilead Sciences's cumulative cost basis changed year-over-year?
- Gilead Sciences's cumulative cost basis increased by 5.8% year-over-year, from $7.96B to $8.42B.
- What is the long-term trend for Gilead Sciences's cumulative cost basis?
- Over 2 years (2020 to 2025), Gilead Sciences's cumulative cost basis has grown at a 102.6% compound annual growth rate (CAGR), from $2.02B to $8.30B.
- What does cumulative cost basis mean?
- The original total cost of assets or liabilities before any accounting adjustments.